Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Dec;86(6):2080–2085. doi: 10.1172/JCI114945

Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma.

D I Marks 1, S P Rockman 1, M A Oziemski 1, R M Fox 1
PMCID: PMC329847  PMID: 2123891

Abstract

Extracorporeal photochemotherapy is an effective treatment for cutaneous T cell lymphoma but its mode of action is uncertain. The reduction in viability of patients' photoirradiated buffy coat lymphocytes was correlated with a 35% increase in DNA single-strand breaks and marked decreases in cellular ATP and NAD levels (to 58 and 34% of control, respectively) immediately after photoirradiation. Complementary in vitro studies were conducted with normal human peripheral blood lymphocytes using a Therakos ultraviolet A (UVA) light box. UVA light was cytotoxic on its own but was potentiated by 8-methoxysporalen. 3-aminobenzamide, a poly (ADP-ribose) synthetase inhibitor, mitigated the cytotoxic effect of ultraviolet A light in the presence of 8-methoxypsoralen in lymphocytes and reduced the amount of nucleotide depletion they caused. 10 J/cm2 of UVA light in the presence of 300 ng/ml 8-methoxypsoralen increased the poly (ADP-ribose) synthetase activity of peripheral blood lymphocytes. Exposing lymphocytes to deoxycoformycin and deoxyadenosine was found to induce biochemical and physical effects similar to those of photochemotherapy. In summary, we have shown that the lymphocytotoxic effect of extracorporeal photochemotherapy for cutaneous T cell lymphoma is apparently mediated by DNA damage, subsequent poly (ADP-ribosyl)ation and adenine nucleotide depletion. It is not known how the DNA damage and resultant biochemical effects relate to the possible immunological mechanism of extracorporeal photochemotherapy; however, it is possible that its effects can be mimicked by other DNA-damaging agents.

Full text

PDF
2080

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Althaus F. R., Richter C. ADP-ribosylation of proteins. Enzymology and biological significance. Mol Biol Biochem Biophys. 1987;37:1–237. [PubMed] [Google Scholar]
  2. Anderson T. F., Voorhees J. J. Psoralen photochemotherapy of cutaneous disorders. Annu Rev Pharmacol Toxicol. 1980;20:235–257. doi: 10.1146/annurev.pa.20.040180.001315. [DOI] [PubMed] [Google Scholar]
  3. Berger N. A. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res. 1985 Jan;101(1):4–15. [PubMed] [Google Scholar]
  4. Berger N. A., Weber G., Kaichi A. S. Characterization and comparison of poly(adenosine dephosphoribose) synthesis and DNA synthesis in nucleotide-permeable cells. Biochim Biophys Acta. 1978 Jun 22;519(1):87–104. doi: 10.1016/0005-2787(78)90064-3. [DOI] [PubMed] [Google Scholar]
  5. Birnboim H. C., Jevcak J. J. Fluorometric method for rapid detection of DNA strand breaks in human white blood cells produced by low doses of radiation. Cancer Res. 1981 May;41(5):1889–1892. [PubMed] [Google Scholar]
  6. Carson D. A., Seto S., Wasson D. B., Carrera C. J. DNA strand breaks, NAD metabolism, and programmed cell death. Exp Cell Res. 1986 Jun;164(2):273–281. doi: 10.1016/0014-4827(86)90028-5. [DOI] [PubMed] [Google Scholar]
  7. Cimino G. D., Gamper H. B., Isaacs S. T., Hearst J. E. Psoralens as photoactive probes of nucleic acid structure and function: organic chemistry, photochemistry, and biochemistry. Annu Rev Biochem. 1985;54:1151–1193. doi: 10.1146/annurev.bi.54.070185.005443. [DOI] [PubMed] [Google Scholar]
  8. Crescentini G., Stocchi V. Fast reversed-phase high-performance liquid chromatographic determination of nucleotides in red blood cells. J Chromatogr. 1984 May 4;290:393–399. doi: 10.1016/s0021-9673(01)93592-7. [DOI] [PubMed] [Google Scholar]
  9. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., Vonderheid E., Knobler R., Wolff K., Plewig G. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med. 1987 Feb 5;316(6):297–303. doi: 10.1056/NEJM198702053160603. [DOI] [PubMed] [Google Scholar]
  10. Ganeshaguru K., Piga A., Latini L., Hoffbrand A. V. Inability of poly-ADP-ribosylation inhibitors to protect peripheral blood lymphocytes from the toxic effects of ADA inhibition. Adv Exp Med Biol. 1989;253B:251–258. doi: 10.1007/978-1-4684-5676-9_37. [DOI] [PubMed] [Google Scholar]
  11. Gilchrest B. A., Parrish J. A., Tanenbaum L., Haynes H. A., Fitzpatrick T. B. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer. 1976 Aug;38(2):683–689. doi: 10.1002/1097-0142(197608)38:2<683::aid-cncr2820380210>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  12. Knobler R. M., Edelson R. L. Cutaneous T cell lymphoma. Med Clin North Am. 1986 Jan;70(1):109–138. doi: 10.1016/s0025-7125(16)30972-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES